Indutrade agrees to acquire Polish medical consumables supplier Sinmed

• Indutrade has agreed to acquire all shares in Poland's Sinmed, its twelfth acquisition of 2026.
• Sinmed specializes in single-use medical products and consumables, with annual sales of approximately PLN 50 million (SEK 130 million).
• Closing is expected in Q4 2026, subject to approval from the Polish competition authority.
• Sinmed will join the Life Science business area. The acquisition is expected to have a marginally positive impact on earnings per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indutrade AB published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.